Thrivent Financial for Lutherans’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-987,450
| Closed | -$40.5M | – | 2467 |
|
2023
Q2 | $40.5M | Buy |
987,450
+54,910
| +6% | +$2.25M | 0.09% | 275 |
|
2023
Q1 | $33.3M | Buy |
932,540
+13,208
| +1% | +$472K | 0.08% | 295 |
|
2022
Q4 | $34.7M | Buy |
919,332
+10,853
| +1% | +$410K | 0.09% | 282 |
|
2022
Q3 | $40.2M | Sell |
908,479
-368,304
| -29% | -$16.3M | 0.11% | 228 |
|
2022
Q2 | $47.3M | Sell |
1,276,783
-284,730
| -18% | -$10.5M | 0.13% | 209 |
|
2022
Q1 | $57.8M | Buy |
1,561,513
+27,514
| +2% | +$1.02M | 0.11% | 223 |
|
2021
Q4 | $46.7M | Buy |
1,533,999
+146,235
| +11% | +$4.45M | 0.09% | 263 |
|
2021
Q3 | $46.5M | Buy |
1,387,764
+1,264,397
| +1,025% | +$42.4M | 0.09% | 253 |
|
2021
Q2 | $4.92M | Buy |
123,367
+2,054
| +2% | +$81.9K | 0.01% | 927 |
|
2021
Q1 | $5.45M | Buy |
+121,313
| New | +$5.45M | 0.01% | 877 |
|
2017
Q4 | – | Sell |
-500
| Closed | -$25K | – | 2164 |
|
2017
Q3 | $25K | Buy |
+500
| New | +$25K | ﹤0.01% | 2061 |
|
2014
Q2 | – | Sell |
-150,200
| Closed | -$6.49M | – | 1722 |
|
2014
Q1 | $6.49M | Buy |
+150,200
| New | +$6.49M | 0.04% | 389 |
|